Evidence map›Paper›PMID 33280409›Full record

ArticleHypertension (Dallas, Tex. : 1979)2021

Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism: Implications for Case Detection.

Nicholas Yozamp, Gregory L Hundemer, Marwan Moussa, Jonathan Underhill, Tali Fudim, Barry Sacks, Anand Vaidya

Registry-linked trialAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06740838 (Overnight Dexamethasone in Primary Aldosteronism Screening in Patients on Interfering Therapy), which is not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06740838 recruitingnot on this mapstarted 2024, after this paper: background citation

Overnight Dexamethasone in Primary Aldosteronism Screening in Patients on Interfering Therapy (the ODEPRASC Study)

TypeobservationalSponsorMedical University of GdanskRan2024 to 2026Enrolled240ConditionsPrimary Aldosteronism, Hypertension
3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. A novel clinical-imaging nomogram for predicting primary aldosteronism in patients with hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Trial
  2. Article
  3. Article
  4. Primary aldosteronism.Nature reviews. Disease primers · 2026
    Review
  5. Article
  6. Effect of collection timing on selectivity index in unstimulated adrenal venous sampling: discovery and validation.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Subclinical primary aldosteronism.Archives of endocrinology and metabolism · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Nicholas YozampFrom the Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital (N.Y., A.V.), Harvard Medical School, Boston, MA.
Gregory L HundemerDivision of Nephrology, The Ottawa Hospital, University of Ottawa, Canada (G.L.H.).
Marwan MoussaDepartment of Radiology, Beth Israel Deaconess Medical Center (M.M., J.U., T.F., B.S.), Harvard Medical School, Boston, MA.
Jonathan UnderhillDepartment of Radiology, Beth Israel Deaconess Medical Center (M.M., J.U., T.F., B.S.), Harvard Medical School, Boston, MA.
Tali FudimDepartment of Radiology, Beth Israel Deaconess Medical Center (M.M., J.U., T.F., B.S.), Harvard Medical School, Boston, MA.
Barry SacksDepartment of Radiology, Beth Israel Deaconess Medical Center (M.M., J.U., T.F., B.S.), Harvard Medical School, Boston, MA.
Anand VaidyaFrom the Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital (N.Y., A.V.), Harvard Medical School, Boston, MA.

Funding

TRAINING PROGRAM IN HYPERTENSIONT32HL007609 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ADLER, GAIL KURR · 1985 to 2022
$10.2M
Unrecognized Primary Aldosteronism as a Pathogenic Mechanism for Chronic Kidney Disease in DiabetesR01DK115392 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI Anand Vaidya · 2018 to 2026
$6.0M
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in ObesityR01HL153004 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI VAIDYA, ANAND · 2020 to 2024
$4.4M
NHLBI NIH HHS R01 HL153004NHLBI NIH HHS T32 HL007609NIDDK NIH HHS R01 DK115392
6 · The paper itself

Abstract

Primary aldosteronism is an underdiagnosed cause of hypertension. Although inadequate screening is one reason for underdiagnosis, another important contributor is that clinicians may inappropriately exclude the diagnosis when screening aldosterone concentrations fall below traditionally established thresholds. We evaluated the intraindividual variability in screening aldosterone concentrations and aldosterone-to-renin ratios, and how this variability could impact case detection, among 51 patients with confirmed primary aldosteronism who had 2 or more screening measurements of renin and aldosterone on different days. There were a total of 137 screening measurements with a mean of 3 (range 2-6) per patient. The mean intraindividual variability, expressed as coefficients of variation, was 31% for aldosterone and 45% for the aldosterone-to-renin ratio. Aldosterone concentrations ranged from 4.9 to 51 ng/dL; 49% of patients had at least one aldosterone measurement below 15 ng/dL, 29% had at least 2 aldosterone measurements below 15 ng/dL, and 29% had at least one measurement below 10 ng/dL. Individual aldosterone-to-renin ratios ranged from 8.2 to 427 ng/dL per ng/mL·hour; 57% had at least one ratio below 30 ng/dL per ng/mL·hour, 27% had at least 2 ratios below 30 ng/dL per ng/mL·hour, and 24% had at least one ratio below 20 ng/dL per ng/mL·hour. Aldosterone concentrations and aldosterone-to-renin ratios are highly variable in patients with primary aldosteronism, with many screening values falling below conventionally accepted diagnostic thresholds. The diagnostic yield for primary aldosteronism may be substantially increased by recalibrating the definition of a positive screen to include more liberal thresholds for aldosterone and the aldosterone-to-renin ratio.

Indexed as

AdultAldosteroneBiological Variation, IndividualChromatography, LiquidFemaleHumansHyperaldosteronismHypertensionMaleMiddle AgedReninRetrospective StudiesSensitivity and SpecificityTandem Mass SpectrometryAldosteroneReninaldosteroneangiotensinsdiagnosisplasmarenin

Identifiers

PMID33280409
PMCPMC7878320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.